Pakistan Health Parliament

Pakistan Health Parliament Rethinking Health, Empowering People | Pakistan's First Think-and-Do Tank | Leading Health Advocacy Platform

03/09/2026

**๐“๐ก๐ž ๐‡๐ข๐ฃ๐š๐œ๐ค๐ž๐ ๐๐ซ๐š๐ข๐ง | ๐’๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž๐**

What if some of our everyday habits are quietly shaping the way our brain works?

The Youth Health Parliament Capital wrapped up an engaging session on "The Hijacked Brain", where participants explored mental health from a different perspective, looking at how social media, junk food, and caffeine can influence our habits, behavior, and relationship with our own minds.

A thought-provoking conversation, plenty of questions, and a perspective worth taking beyond the session.

A big thank you to Aniqa Ayzal for making the session insightful and relatable, and to everyone who joined the conversation.

31/08/2026

๐€๐ˆ, ๐๐จ๐ฅ๐ข๐œ๐ฒ & ๐ญ๐ก๐ž ๐๐ž๐ฑ๐ญ ๐‚๐ก๐š๐ฉ๐ญ๐ž๐ซ ๐Ÿ๐จ๐ซ ๐๐ก๐š๐ซ๐ฆ๐š

In this segment of the Industry Collective Roundtable on the Future of Pharmaceutical Industry in Pakistan, Muhammad Salman Khan and Dr. Ashar Malik shared their perspectives on what lies ahead for the industry.

Muhammad Salman Khan looked at the future through the lens of AI, digital health and innovation, while Dr. Ashar Malik examined it from the economic and policy perspective and what these factors could mean for the industry's sustainability and growth.

Dr. Nadim Rehman also added his perspective on the use of technology in the future of the pharmaceutical industry in Pakistan.

๐๐ซ๐จ๐œ๐ซ๐š๐ฌ๐ญ๐ข๐ง๐š๐ญ๐ข๐จ๐ง ๐ˆ๐ฌ๐งโ€™๐ญ ๐‹๐š๐ณ๐ข๐ง๐ž๐ฌ๐ฌ: ๐–๐ž๐›๐ข๐ง๐š๐ซ ๐’๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ๐Ÿ๐ฎ๐ฅ๐ฅ๐ฒ ๐‚๐จ๐ง๐œ๐ฅ๐ฎ๐๐ž๐The Youth Mental Health Committee โ€“ K Chapter, Pakistan He...
29/08/2026

๐๐ซ๐จ๐œ๐ซ๐š๐ฌ๐ญ๐ข๐ง๐š๐ญ๐ข๐จ๐ง ๐ˆ๐ฌ๐งโ€™๐ญ ๐‹๐š๐ณ๐ข๐ง๐ž๐ฌ๐ฌ: ๐–๐ž๐›๐ข๐ง๐š๐ซ ๐’๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ๐Ÿ๐ฎ๐ฅ๐ฅ๐ฒ ๐‚๐จ๐ง๐œ๐ฅ๐ฎ๐๐ž๐

The Youth Mental Health Committee โ€“ K Chapter, Pakistan Health Parliament successfully conducted an engaging virtual masterclass today on โ€œProcrastination Isnโ€™t Laziness: The Neuroscience of Task Aversion.

Led by Huma Ali, the session challenged a common assumption: that putting things off simply means weโ€™re lazy. Instead, participants explored what happens in the brain when a task feels overwhelming, uncomfortable, or threatening and why getting started can sometimes feel harder than the task itself.

The session was met with great enthusiasm and active participation, making it an insightful and relatable conversation for everyone who joined.

Sometimes, the problem isnโ€™t a lack of motivation. Itโ€™s understanding whatโ€™s holding us back.

29/08/2026

๐–๐ก๐š๐ญ ๐ƒ๐จ๐ž๐ฌ ๐ญ๐ก๐ž ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐‡๐จ๐ฅ๐ ๐Ÿ๐จ๐ซ ๐๐ก๐š๐ซ๐ฆ๐š ๐ข๐ง ๐๐š๐ค๐ข๐ฌ๐ญ๐š๐ง?

In this segment of the Industry Collective Roundtable on the Future of Pharmaceutical Industry in Pakistan, Ahmed Iqbal, Dr. Muhammad Haleem, and Dr. Nadim Rehman were asked a straightforward but critical question:

โ€œWhat is the future outlook of pharmaceutical companies in Pakistan?โ€

Their responses bring different perspectives on the challenges ahead, the changing market, and the opportunities that could shape the industry in the years to come.

Watch the discussion.

29/08/2026

๐‚๐š๐ง ๐ƒ๐ข๐ ๐ข๐ญ๐š๐ฅ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐’๐ญ๐ข๐ฅ๐ฅ ๐Œ๐จ๐ฏ๐ž ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐ซ๐ฐ๐š๐ซ๐?

In this segment of the Industry Collective Roundtable on the Future of Pharmaceutical Industry in Pakistan, Muhammad Salman Khan raised a timely question:

๐‘ฏ๐’๐’˜ ๐’˜๐’Š๐’๐’ ๐’…๐’Š๐’ˆ๐’Š๐’•๐’‚๐’ ๐’‰๐’†๐’‚๐’๐’•๐’‰ ๐’†๐’—๐’๐’๐’—๐’† ๐’‚๐’๐’… ๐’”๐’๐’๐’—๐’† ๐’•๐’‰๐’† ๐’„๐’–๐’“๐’“๐’†๐’๐’• ๐’‘๐’“๐’๐’ƒ๐’๐’†๐’Ž๐’” ๐’๐’‡ ๐’‘๐’‰๐’‚๐’“๐’Ž๐’‚ ๐’˜๐’‰๐’†๐’ ๐’•๐’‰๐’† ๐’Š๐’๐’๐’๐’—๐’‚๐’•๐’Š๐’—๐’† ๐’Ž๐’๐’…๐’†๐’๐’” ๐’‚๐’๐’… ๐’”๐’•๐’‚๐’“๐’•๐’–๐’‘ ๐’†๐’„๐’๐’”๐’š๐’”๐’•๐’†๐’Ž ๐’‰๐’‚๐’—๐’† ๐’„๐’๐’๐’๐’‚๐’‘๐’”๐’†๐’…?

The discussion then moved to how digital health has already begun changing access to care.

Dr. Nadim Rehman shared his perspective on the impact of telemedicine, e-pharmacies and micro-insurance and how these models can help expand access to healthcare in Pakistan.

A candid discussion on where digital health stands today, and where it can go next.

29/08/2026

๐๐จ๐ฅ๐ข๐œ๐ฒ ๐จ๐ซ ๐๐จ๐ฅ๐ข๐œ๐ข๐ง๐ ?

In this segment of the Industry Collective Roundtable on the Future of Pharmaceutical Industry in Pakistan, Dr. Ashar Malik took a candid look at the economic and policy challenges affecting the pharmaceutical industry.

He highlighted how financial frameworks are putting pressure on product lines and companies, while unethical practices are adding to the cost of doing business. His message was clear: we need to focus on better policy rather than simply โ€œpolicingโ€ the industry.

He also pointed to another fundamental gap, the lack of comprehensive data and research in Pakistan, making informed policy decisions even more difficult.

The discussion then took an interesting turn when Dr. Muhammad Haleem asked:
โ€œ๐‡๐จ๐ฐ ๐ฏ๐ข๐š๐›๐ฅ๐ž ๐ข๐ฌ โ€˜๐จ๐ง๐ž ๐ฆ๐จ๐ฅ๐ž๐œ๐ฎ๐ฅ๐ž, ๐ญ๐ฐ๐จ ๐ฉ๐ซ๐ข๐œ๐ž๐ฌโ€™ ๐ข๐ง ๐๐š๐ค๐ข๐ฌ๐ญ๐š๐ง?โ€

A candid exchange on pricing, policy and the economics of Pakistanโ€™s pharmaceutical industry.

27/08/2026

๐–๐ก๐ฒ ๐ก๐š๐ฏ๐ž ๐ฆ๐ฎ๐ฅ๐ญ๐ข๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐ฌ๐ญ๐จ๐ฉ๐ฉ๐ž๐ ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐ข๐ง๐  ๐š๐ง๐ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐  ๐ข๐ง ๐๐š๐ค๐ข๐ฌ๐ญ๐š๐ง?

A direct question. A candid response.

In this segment of the Industry Collective Roundtable on the Future of Pharmaceutical Industry in Pakistan, Dr. Nadim Rehman shares his perspective on what is holding back multinational investment and manufacturing in Pakistan and what needs to change.

Watch his response.

27/08/2026

๐–๐ก๐š๐ญ ๐ข๐ฌ ๐ก๐จ๐ฅ๐๐ข๐ง๐  ๐ข๐ญ ๐›๐š๐œ๐ค, ๐š๐ง๐ ๐ฐ๐ก๐š๐ญ ๐ง๐ž๐ž๐๐ฌ ๐ญ๐จ ๐œ๐ก๐š๐ง๐ ๐ž?

At the virtual Industry Collective Roundtable on "The Future of Pharmaceutical Industry in Pakistan", Dr. Muhammad Haleem, Dr. Nadim Rehman, and Dr. Ashar Malik examined the technical, business and economic challenges shaping the industry and what these realities mean for its future.

A discussion on where the industry stands, what is holding it back, and what needs to change.

25/08/2026

At the Industry Collective Roundtable on the Future of Pharmaceutical Industry in Pakistan, two important questions went straight to the heart of the industryโ€™s sustainability.

Mr. Ahmed Iqbal, Ex- COO, Platinum Pharmaceuticals, was asked:
โ€œWhen have tight economic challenges in Pakistan stopped making commercial sense for pharma companies?โ€

Dr. Muhammad Haleem, Director Plants, Astellas Pharma, was asked:
โ€œHow have manufacturing costs risen over the last five years?โ€

25/08/2026

๐๐ก๐š๐ซ๐ฆ๐šโ€™๐ฌ ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐ง๐ž๐ž๐๐ฌ ๐ฆ๐จ๐ซ๐ž ๐ญ๐ก๐š๐ง ๐จ๐ง๐ž ๐ฉ๐ž๐ซ๐ฌ๐ฉ๐ž๐œ๐ญ๐ข๐ฏ๐ž.

At the latest Industry Collective Roundtable by Pakistan Health Parliament, the conversation moved beyond the usual debate around the pharmaceutical sector.

Dr. Muhammad Haleem brought the technical and manufacturing perspective, looking at the realities of producing medicines in Pakistan and what needs to change for a stronger manufacturing base.

Mr. Muhammad Salman Khan opened the discussion from the digital health and innovation perspective, bringing in the role technology and new models can play in shaping the future of the industry.

Two different lenses. One larger question:

Can Pakistan build a pharmaceutical industry that is competitive, innovative and sustainable?

Address

Islamabad
44000

Website

Alerts

Be the first to know and let us send you an email when Pakistan Health Parliament posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share